ERα-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNFα and IL1α in lumen formation and maintenance

Journal of Cell Science

Volumn 125, Issue 8, 2012, Pages 1929-1944

  Eritja, Nuria ^a,b   Mirantes, Cristina ^a,b   Llobet, David ^a,b   Masip, Gemma ^a,b   Matias Guiu, Xavier ^a,b   Dolcet, Xavi ^a,b  

^a UNIVERSITY OF LLEIDA   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

Epithelial cell polarity; ER ; ERK MAPK; Lumen; Pro inflammatory cytokines

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL POLARITY; CONTROLLED STUDY; ENDOMETRIUM CELL; ENZYME ACTIVATION; FEMALE; GENE REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UTERUS CAVITY;

ANIMALS; CELL POLARITY; DOWN-REGULATION; ENDOMETRIUM; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; INFLAMMATION MEDIATORS; INTERLEUKIN-1ALPHA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863092722     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.095067     Document Type: Article

References (70)

1. Aggarwal, B. B. (2003). Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756.
2. Barnes, P. J. (2006). How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br. J. Pharmacol. 148, 245-254.
3. Baud, V. and Karin, M. (2001). Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377.
4. Bergman, M. D., Schachter, B. S., Karelus, K., Combatsiaris, E. P., Garcia, T. and Nelson, J. F. (1992). Up-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle: the role of estradiol. Endocrinology 130, 1923-1930.
5. Bonifacino, J. S. and Glick, B. S. (2004). The mechanisms of vesicle budding and fusion. Cell 116, 153-166.
6. Bryant, D. M. and Mostov, K. E. (2008). From cells to organs: building polarized tissue. Nat. Rev. Mol. Cell Biol. 9, 887-901.
7. Bussaglia, E., del Rio, E., Matias-Guiu, X. and Prat, J. (2000). PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum. Pathol. 31, 312-317.
8. Cai, H., Reinisch, K. and Ferro-Novick, S. (2007). Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle. Dev. Cell 12, 671-682.
9. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
10. Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J. A. and Korach, K. S. (1997). Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138, 4613-4621.
11. Cuzzocrea, S., Bruscoli, S., Crisafulli, C., Mazzon, E., Agostini, M., Muia, C., Esposito, E., Di Virgilio, R., Meli, R., Vegeto, E. et al. (2007). Estrogen receptor antagonist fulvestrant (ICI 182,780) inhibits the anti-inflammatory effect of glucocorticoids. Mol. Pharmacol. 71, 132-144.
12. Cvoro, A., Tzagarakis-Foster, C., Tatomer, D., Paruthiyil, S., Fox, M. S. and Leitman, D. C. (2006). Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol. Cell 21, 555-564.
13. Cvoro, A., Yuan, C., Paruthiyil, S., Miller, O. H., Yamamoto, K. R. and Leitman, D. C. (2011). Cross talk between glucocorticoid and estrogen receptors occurs at a subset of proinflammatory genes. J. Immunol. 186, 4354-4360.
14. Debnath, J., Mills, K. R., Collins, N. L., Reginato, M. J., Muthuswamy, S. K. and Brugge, J. S. (2002). The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29-40.
15. Debnath, J., Muthuswamy, S. K. and Brugge, J. S. (2003). Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268.
16. Debnath, J., Walker, S. J. and Brugge, J. S. (2003). Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. J. Cell Biol. 163, 315-326.
17. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. and Pandolfi, P. P. (1998). Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348-355.
18. Elsdale, T. and Bard, J. (1972). Collagen substrata for studies on cell behavior. J. Cell Biol. 54, 626-637.
19. Emerman, J. T. and Pitelka, D. R. (1977). Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro 13, 316-328.
20. Emerman, J. T., Burwen, S. J. and Pitelka, D. R. (1979). Substrate properties influencing ultrastructural differentiation of mammary epithelial cells in culture. Tissue Cell 11, 109-119.
21. Eritja, N., Llobet, D., Domingo, M., Santacana, M., Yeramian, A., Matias-Guiu, X. and Dolcet, X. (2010). A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis. Am. J. Pathol. 176, 2722-2731.
22. Fata, J. E., Mori, H., Ewald, A. J., Zhang, H., Yao, E., Werb, Z. and Bissell, M. J. (2007). The MAPERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium. Dev. Biol. 306, 193-207.
23. Fournier, M. V., Fata, J. E., Martin, K. J., Yaswen, P. and Bissell, M. J. (2009). Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells. Cancer Res. 69, 4545-4552.
24. Gassama-Diagne, A., Yu, W., ter Beest, M., Martin-Belmonte, F., Kierbel, A., Engel, J. and Mostov, K. (2006). Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat. Cell Biol. 8, 963-970.
25. Gaur, U. and Aggarwal, B. B. (2003). Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem. Pharmacol. 66, 1403-1418.
26. Hall, H. G., Farson, D. A. and Bissell, M. J. (1982). Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc. Natl. Acad. Sci. USA 79, 4672-4676.
27. Hayashi, R., Wada, H., Ito, K. and Adcock, I. M. (2004). Effects of glucocorticoids on gene transcription. Eur. J. Pharmacol. 500, 51-62.
28. Hebner, C., Weaver, V. M. and Debnath, J. (2008). Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures. Annu. Rev. Pathol. 3, 313-339.
29. Hild-Petito, S., Verhage, H. G. and Fazleabas, A. T. (1992). Immunocytochemical localization of estrogen and progestin receptors in the baboon (Papio anubis) uterus during implantation and pregnancy. Endocrinology 130, 2343-2353.
30. Hommes, D. W., Peppelenbosch, M. P. and van Deventer, S. J. (2003). Mitogen activated protein (MAP) kinase signal transduction pathways and novel antiinflammatory targets. Gut 52, 144-151.
31. Howe, A. K., Aplin, A. E. and Juliano, R. L. (2002). Anchorage-dependent ERK signaling - mechanisms and consequences. Curr. Opin. Genet Dev. 12, 30-35.
32. Jaffe, A. B., Kaji, N., Durgan, J. and Hall, A. (2008). Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis. J. Cell Biol. 183, 625-633.
33. Kaminska, B. (2005). MAPK signalling pathways as molecular targets for antiinflammatory therapy - from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta. 1754, 2532-2562.
34. Karin, M. (2004). Mitogen activated protein kinases as targets for development of novel anti-inflammatory drugs. Ann. Rheum. Dis. 63 Suppl. 2, ii62-ii64.
35. Kelso, A. (1994). The enigma of cytokine redundancy. Immunol. Cell Biol. 72, 97-101.
36. Kim, J. B. (2005). Three-dimensional tissue culture models in cancer biology. Semin. Cancer Biol. 15, 365-377.
37. Kim, J. B., Stein, R. and O'Hare, M. J. (2004). Three-dimensional in vitro tissue culture models of breast cancer - a review. Breast. Cancer Res. Treat 85, 281-291.
38. Koji, T. and Brenner, R. M. (1993). Localization of estrogen receptor messenger ribonucleic acid in rhesus monkey uterus by nonradioactive in situ hybridization with digoxigenin-labeled oligodeoxynucleotides. Endocrinology 132, 382-392.
39. Lessey, B. A., Killam, A. P., Metzger, D. A., Haney, A. F., Greene, G. L. and McCarty, K. S., Jr (1988). Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J. Clin. Endocrinol. Metab. 67, 334-340.
40. Lipschutz, J. H., O'Brien, L. E., Altschuler, Y., Avrahami, D., Nguyen, Y., Tang, K. and Mostov, K. E. (2001). Analysis of membrane traffic in polarized epithelial cells. Curr. Protoc. Cell Biol. Chapter 15, Unit 15 5.
41. Llobet, D., Eritja, N., Encinas, M., Llecha, N., Yeramian, A., Pallares, J., Sorolla, A., Gonzalez-Tallada, F. J., Matias-Guiu, X. and Dolcet, X. (2008). CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells. Oncogene 27, 2513-2524.
42. Llobet, D., Pallares, J., Yeramian, A., Santacana, M., Eritja, N., Velasco, A., Dolcet, X. and Matias-Guiu, X. (2009). Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints. J. Clin. Pathol. 62, 777-785.
43. Mailleux, A. A., Overholtzer, M., Schmelzle, T., Bouillet, P., Strasser, A. and Brugge, J. S. (2007). BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev. Cell 12, 221-234.
44. Mailleux, A. A., Overholtzer, M. and Brugge, J. S. (2008). Lumen formation during mammary epithelial morphogenesis: insights from in vitro and in vivo models. Cell Cycle 7, 57-62.
45. Martin-Belmonte, F. and Mostov, K. (2007). Phosphoinositides control epithelial development. Cell Cycle 6, 1957-1961.
46. Martin-Belmonte, F. and Mostov, K. (2008). Regulation of cell polarity during epithelial morphogenesis. Curr. Opin. Cell Biol. 20, 227-234.
47. Martin-Belmonte, F., Gassama, A., Datta, A., Yu, W., Rescher, U., Gerke, V. and Mostov, K. (2007). PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128, 383-397.
48. Martin-Belmonte, F., Yu, W., Rodriguez-Fraticelli, A. E., Ewald, A. J., Werb, Z., Alonso, M. A. and Mostov, K. (2008). Cell-polarity dynamics controls the mechanism of lumen formation in epithelial morphogenesis. Curr. Biol. 18, 5075-5013.
49. Mathew, S. J., Haubert, D., Kronke, M. and Leptin, M. (2009). Looking beyond death: a morphogenetic role for the TNF signalling pathway. J. Cell Sci. 122, 1939-1946.
50. Myllymaki, S. M., Teravainen, T. P. and Manninen, A. (2011). Two distinct integrinmediated mechanisms contribute to apical lumen formation in epithelial cells. PLoS ONE 6, e19453.
51. Nelson, W. J. (2009). Remodeling epithelial cell organization: transitions between frontrear and apical-basal polarity. Cold Spring Harb. Perspect. Biol. 1, a000513.
52. O'Brien, L. E., Jou, T. S., Pollack, A. L., Zhang, Q., Hansen, S. H., Yurchenco, P. and Mostov, K. E. (2001). Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly. Nat. Cell Biol. 3, 831-838.
53. Ozaki, K. and Leonard, W. J. (2002). Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 277, 29355-29358.
54. Ozato-Sakurai, N., Fujita, A. and Fujimoto, T. (2011). The distribution of phosphatidylinositol 4,5-bisphosphate in acinar cells of rat pancreas revealed with the freeze-fracture replica labeling method. PLoS ONE 6, e23567.
55. Paul, W. E. (1989). Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell 57, 521-524.
56. Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E. and Parsons, R. (1999). Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA 96, 1563-1568.
57. Pullikuth, A. K. and Catling, A. D. (2007). Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell. Signal. 19, 1621-1632.
58. Rodriguez-Fraticelli, A. E., Vergarajauregui, S., Eastburn, D. J., Datta, A., Alonso, M. A., Mostov, K. and Martin-Belmonte, F. (2010). The Cdc42 GEF Intersectin 2 controls mitotic spindle orientation to form the lumen during epithelial morphogenesis. J. Cell Biol. 189, 725-738.
59. Schmidt, T. J. and Meyer, A. S. (1994). Autoregulation of corticosteroid receptors. How, when, where, and why? Receptor 4, 229-257.
60. Shaul, Y. D. and Seger, R. (2007). The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 1773, 1213-1226.
61. Shaw, K. R., Wrobel, C. N. and Brugge, J. S. (2004). Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis. J. Mammary Gland Biol. Neoplasia 9, 297-310.
62. Snijders, M. P., de Goeij, A. F., Debets-Te, Baerts, M. J, Rousch, M. J, Koudstaal, J. and Bosman, F. T. (1992). Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J. Reprod. Fertil. 94, 363-371.
63. Velasco, A., Bussaglia, E., Pallares, J., Dolcet, X., Llobet, D., Encinas, M., Llecha, N., Palacios, J., Prat, J. and Matias-Guiu, X. (2006). PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations. Hum. Pathol. 37, 1465-1472.
64. Viala, E. and Pouyssegur, J. (2004). Regulation of tumor cell motility by ERK mitogen-activated protein kinases. Ann. New York Acad. Sci. 1030, 208-218.
65. Wajant, H., Pfizenmaier, K. and Scheurich, P. (2003). Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65.
66. Whyte, J., Bergin, O., Bianchi, A., McNally, S. and Martin, F. (2009). Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res. 11, 209.
67. Yamada, K. M. and Cukierman, E. (2007). Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601-610.
68. Yee, K. L., Weaver, V. M. and Hammer, D. A. (2008). Integrin-mediated signalling through the MAP-kinase pathway. IET Syst. Biol. 2, 8-15.
69. Yu, W., O'Brien, L. E., Wang, F., Bourne, H., Mostov, K. E. and Zegers, M. M. (2003). Hepatocyte growth factor switches orientation of polarity and mode of movement during morphogenesis of multicellular epithelial structures. Mol. Biol. Cell 14, 748-763.
70. Yu, W., Datta, A., Leroy, P., O'Brien, L. E., Mak, G., Jou, T. S., Matlin, K. S., Mostov, K. E. and Zegers, M. M. (2005). Beta1-integrin orients epithelial polarity via Rac1 and laminin. Mol. Biol. Cell 16, 433-445.